European Commission and EIB Group Launch €10 Billion Initiative to Strengthen Europe’s Biotech Sector

The European Commission and the European Investment Bank (EIB) Group today announced a new joint initiative aimed at mobilising €10 billion in investment to support the growth and global competitiveness of Europe’s biotechnology and life sciences sector.

The initiative, BioTechEU, will be rolled out over 2026–2027 and is designed to address Europe’s longstanding investment gap in biotechnology by unlocking additional public and private capital. It will support innovative companies across the EU, from start-ups and scale-ups to more mature firms, helping them bring cutting-edge technologies to market.

BioTechEU will focus on strategic areas of biotechnology, including gene and cell therapies, personalised medicine, mRNA technologies, monoclonal antibodies, diagnostics, and artificial intelligence-enabled medical solutions. By strengthening access to finance, the initiative aims to accelerate innovation, improve healthcare outcomes, and reinforce Europe’s technological sovereignty.

The programme will be implemented under the EIB Group’s TechEU platform, which supports the development and scaling of critical technologies in Europe. It will also leverage existing EU instruments, including the InvestEU guarantee, to de-risk investments and attract private-sector participation.

BioTechEU builds on the EIB Group’s strong track record in life sciences financing. To date, the EIB has supported approximately €3.5 billion in life sciences venture debt across more than 135 projects, while the European Investment Fund (EIF) invests around €800 million annually in life sciences-focused venture capital funds.

By mobilising large-scale investment and encouraging greater risk-sharing, the European Commission and the EIB Group aim to create a more robust and competitive biotech ecosystem in Europe, capable of retaining talent, scaling innovation, and competing globally.

The initiative is expected to act as a catalyst for future investment and could pave the way for additional EU-level financing instruments dedicated to health and biotechnology.

LATEST NEWS

News

Coordinating EU collaborative projects

Coordinating EU collaborative projects: when execution marks the difference Lucía Duque Teva( Project Manager European Funds )Settings Coordinating a European collaborative project goes far beyond convening meetings or collecting deliverables….

Read more
News

EU Added Value in LIFE Proposals

EU Added Value in LIFE Proposals Fernando Gómez( Technical Manager – European Funds )Fernando Gómez es Technical Manager – EU Projects en Euro-Funding desde 2020, con experiencia coordinando propuestas europeas…

Read more